| Home Forums |
|
|||||||
| Clinical Trials Considering or participating in research studies |
 |
|
|
Thread Tools | Search this Thread |
|
#1
Mon Jun 26, 2017, 05:02 PM
|
|||
|
|||
NIH Trial (Eltrombopag & Cyclosporine)
My was is currently in 6 month trial @ NIH. She's starting taking both Eltrombopag & Cyclosporine , and was taken off Eltrombopag and taking only Cyclosporine. She is entering 5 month of trial, concern is her platelet count has been dropping over the 4 months ( 138, 120,11 & 99 most recently). NIH does not seem concerned. She may have a cold or virus.
Question - Has anyone had similar experience ? Does platelet count drop near the end of the trial? Appreciate any feedback  
|
|
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| New Promacta (Eltrombopag) Clinical Trial at NIH | Sally C | Clinical Trials | 73 | Sun Dec 30, 2018 05:52 AM |
| NIH Trial - Plt Count Level Feedback/Experience | disco3md | AA | 1 | Wed Jun 28, 2017 01:08 PM |
| Accepted into Campath Trial at NIH | Greg H | Drugs and Drug Treatments | 279 | Wed Aug 31, 2011 09:44 PM |
| Eltrombopag can decrease leukemia cell proloferation | Birgitta-A | Drugs and Drug Treatments | 1 | Fri Nov 9, 2007 03:58 PM |
